Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein.
Emily R Theisen, Julia Selich-Anderson, Kyle R Miller, Jason M Tanner, Cenny Taslim, Kathleen I Pishas, Sunil Sharma, Stephen L Lessnick
Epigenetics | Published : 2021
Paediatric cancers commonly harbour quiet mutational landscapes and are instead characterized by single driver events such as the mutation of critical chromatin regulators, expression of oncohistones, or expression of oncogenic fusion proteins. These events ultimately promote malignancy through disruption of normal gene regulation and development. The driver protein in Ewing sarcoma, EWS/FLI, is an oncogenic fusion and transcription factor that reshapes the enhancer landscape, resulting in widespread transcriptional dysregulation. Lysine-specific demethylase 1 (LSD1) is a critical functional partner for EWS/FLI as inhibition of LSD1 reverses the transcriptional activity of EWS/FLI. However, ..View full abstract